Login / Signup

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials.

Sean M MurphyPhilip J JengSabrina A PooleAli JalaliFrank J VocciMichael S GordonGeorge E WoodyDaniel Polsky
Published in: Addiction science & clinical practice (2020)
Initiating XR-NTX for OUD prior to release from incarceration may improve patient health and well-being, while also producing downstream cost-offsets. This study offers the unique opportunity to assess the effectiveness and cost-effectiveness of multiple strategies, according to different stakeholder perspectives.
Keyphrases